Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Capital Leases (2016 - 2020)

Outlook Therapeutics (OTLK) has disclosed Capital Leases for 6 consecutive years, with $49162.0 as the latest value for Q2 2020.

  • Quarterly Capital Leases fell 98.53% to $49162.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $49162.0 through Jun 2020, down 98.53% year-over-year, with the annual reading at $3.4 million for FY2019, 2.53% down from the prior year.
  • Capital Leases for Q2 2020 was $49162.0 at Outlook Therapeutics, down from $3.3 million in the prior quarter.
  • The five-year high for Capital Leases was $3.5 million in Q1 2018, with the low at $28067.0 in Q3 2017.
  • Average Capital Leases over 5 years is $1.8 million, with a median of $2.1 million recorded in 2016.
  • The sharpest move saw Capital Leases soared 12203.62% in 2018, then crashed 98.53% in 2020.
  • Over 5 years, Capital Leases stood at $113082.0 in 2016, then crashed by 62.43% to $42481.0 in 2017, then skyrocketed by 7903.87% to $3.4 million in 2018, then decreased by 1.64% to $3.3 million in 2019, then crashed by 98.53% to $49162.0 in 2020.
  • According to Business Quant data, Capital Leases over the past three periods came in at $49162.0, $3.3 million, and $3.3 million for Q2 2020, Q1 2020, and Q4 2019 respectively.